Restless legs syndrome due to brainstem stroke: A systematic review.


Journal

Acta neurologica Scandinavica
ISSN: 1600-0404
Titre abrégé: Acta Neurol Scand
Pays: Denmark
ID NLM: 0370336

Informations de publication

Date de publication:
Nov 2022
Historique:
revised: 05 08 2022
received: 29 06 2022
accepted: 21 08 2022
pubmed: 6 9 2022
medline: 18 10 2022
entrez: 5 9 2022
Statut: ppublish

Résumé

Restless Legs Syndrome (RLS) is a sleep-related movement disorder, which can also result from brainstem pathology. A systematic review of articles published in the electronic databases PubMed and Web of Science was conducted to summarize the existent literature on RLS associated with a brainstem stroke. We identified eight articles including 19 subjects with RLS due to brainstem ischemic lesion. The symptoms occurred simultaneously with the infarction (66.7%) or few days after (33.3%). The most common location of infarction was pons and less commonly medulla. In most cases (68.4%), symptoms were unilateral. In the majority of those cases (92.3%), the contralateral limb was affected due to a lateral pons infarction. RLS symptoms after infarction improved or resolved in almost 90% of cases within a few days up to 3 months. In almost all patients who received dopaminergic treatment (11 out of 13, 91.7%), the symptoms improved significantly or resolved completely. Screening for RLS has to be considered in patients suffering a brainstem stroke, particularly anteromedial pontine infarction. The appearance of acute unilateral RLS symptoms, usually in association with other sensorimotor deficits, should prompt the clinician to consider a vascular event in the brainstem. RLS in these cases seem to have a favorable outcome and respond well to dopaminergic treatment.

Identifiants

pubmed: 36063288
doi: 10.1111/ane.13702
doi:

Substances chimiques

Dopamine VTD58H1Z2X

Types de publication

Journal Article Review Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

440-447

Informations de copyright

© 2022 The Authors. Acta Neurologica Scandinavica published by John Wiley & Sons Ltd.

Références

Allen RP, Picchietti DL, Garcia-Borreguero D, et al. Restless legs syndrome/Willis-Ekbom disease diagnostic criteria: updated international restless legs syndrome study group (IRLSSG) consensus criteria--history, rationale, description, and significance. Sleep Med. 2014;15(8):860-873.
Romero-Peralta S, Cano-Pumarega I, García-Borreguero D. Emerging concepts of the pathophysiology and adverse outcomes of restless legs syndrome. Chest. 2020;158(3):1218-1229.
Allen RP. Restless leg syndrome/Willis-Ekbom disease pathophysiology. Sleep Med Clin. 2015;10(3):207-214.
Ferré S, García-Borreguero D, Allen RP, Earley CJ. New insights into the neurobiology of restless legs syndrome. Neuroscientist. 2019;25(2):113-125.
Trenkwalder C, Paulus W. Restless legs syndrome: pathophysiology, clinical presentation and management. Nat Rev Neurol. 2010;6(6):337-346.
Ferri R, Rundo F, Zucconi M, et al. An evidence-based analysis of the association between periodic leg movements during sleep and arousals in restless legs syndrome. Sleep. 2015;38(6):919-924.
Winkelman JW, Finn L, Young T. Prevalence and correlates of restless legs syndrome symptoms in the Wisconsin sleep cohort. Sleep Med. 2006;7(7):545-552.
Tuo H, Tian Z, Ma X, et al. Clinical and radiological characteristics of restless legs syndrome following acute lacunar infarction. Sleep Med. 2019;53:81-87.
Shiina T, Suzuki K, Okamura M, Matsubara T, Hirata K. Restless legs syndrome and its variants in acute ischemic stroke. Acta Neurol Scand. 2019;139(3):260-268.
Woo HG, Lee D, Hwang KJ, Ahn TB. Post-stroke restless leg syndrome and periodic limb movements in sleep. Acta Neurol Scand. 2017;135(2):204-210.
Felix S, Thobois S, Peter-Derex L. Rapid eye movement sleep behaviour disorder symptomatic of a brain stem cavernoma. J Sleep Res. 2016;25(2):211-215.
Veauthier C. Sleep disorders in multiple sclerosis. Review. Curr Neurol Neurosci Rep. 2015;15(5):21.
Gómez-Choco MJ, Iranzo A, Blanco Y, Graus F, Santamaria J, Saiz A. Prevalence of restless legs syndrome and REM sleep behavior disorder in multiple sclerosis. Mult Scler. 2007;13(6):805-808.
Walters AS, LeBrocq C, Dhar A, et al. Validation of the international restless legs syndrome study group rating scale for restless legs syndrome. Sleep Med. 2003;4(2):121-132.
Shi GM, Wang XR, Xu W, Guo MW, Ding CQ, Zhou RJ. Pontine warning syndrome and restless legs syndrome secondary to paramedian pontine infarction: a case report. Int J Neurosci. 2020;1-6:881-884.
Ma LL, Wang YY, Yang ZH, Huang D, Weng H, Zeng XT. Methodological quality (risk of bias) assessment tools for primary and secondary medical studies: what are they and which is better? Mil Med Res. 2020;7(1):7.
Han SH, Park KY, Youn YC, Shin HW. Restless legs syndrome and akathisia as manifestations of acute pontine infarction. J Clin Neurosci. 2014;21(2):354-355.
Lee SJ, Kim JS, Song IU, An JY, Kim YI, Lee KS. Poststroke restless legs syndrome and lesion location: anatomical considerations. Mov Disord. 2009;24(1):77-84.
Margariti PN, Astrakas LG, Tsouli SG, Hadjigeorgiou GM, Konitsiotis S, Argyropoulou MI. Investigation of unmedicated early onset restless legs syndrome by voxel-based morphometry, T2 relaxometry, and functional MR imaging during the night-time hours. AJNR Am J Neuroradiol. 2012;33(4):667-672.
Wetter TC, Eisensehr I, Trenkwalder C. Functional neuroimaging studies in restless legs syndrome. Sleep Med. 2004;5(4):401-406.
Godau J, Wevers AK, Gaenslen A, et al. Sonographic abnormalities of brainstem structures in restless legs syndrome. Sleep Med. 2008;9(7):782-789.
Trenkwalder C, Paulus W. Why do restless legs occur at rest?--pathophysiology of neuronal structures in RLS. Neurophysiology of RLS (part 2). Clin Neurophysiol. 2004;115(9):1975-1988.
Rizzo G, Li X, Galantucci S, Filippi M, Cho YW. Brain imaging and networks in restless legs syndrome. Sleep Med. 2017;31:39-48.
Ruppert E, Kilic-Huck U, Wolff V, et al. Brainstem stroke-related restless legs syndrome: frequency and anatomical considerations. Eur Neurol. 2015;73(1-2):113-118.
Ruppert E, Kilic-Huck U, Wolff V, et al. Restless legs syndrome as a first manifestation of a cerebral infarct. J Clin Sleep Med. 2014;10(9):1037-1038.
Koo BB, Bagai K, Walters AS. Restless legs syndrome: current concepts about disease pathophysiology. Tremor Other Hyperkinet Mov (N Y). 2016;6:401.
Xu Z, Han T, Li T, et al. Increased gray matter density and functional connectivity of the pons in restless legs syndrome. Nature and Science of Sleep. 2020;12:221-230.
Mogavero MP, Mezzapesa DM, Savarese M, DelRosso LM, Lanza G, Ferri R. Morphological analysis of the brain subcortical gray structures in restless legs syndrome. Sleep Med. 2021;88:74-80.
Takakusaki K, Saitoh K, Harada H, Kashiwayanagi M. Role of basal ganglia-brainstem pathways in the control of motor behaviors. Neurosci Res. 2004;50(2):137-151.
Trenkwalder C, Allen R, Högl B, et al. Comorbidities, treatment, and pathophysiology in restless legs syndrome. Lancet Neurol. 2018;17(11):994-1005.
Earley CJ, Connor J, Garcia-Borreguero D, et al. Altered brain iron homeostasis and dopaminergic function in restless legs syndrome (Willis-Ekbom disease). Sleep Med. 2014;15(11):1288-1301.
Connor JR, Wang XS, Allen RP, et al. Altered dopaminergic profile in the putamen and substantia nigra in restless leg syndrome. Brain. 2009;132(Pt 9):2403-2412.
Rizzo G, Tonon C, Manners D, Testa C, Lodi R. Imaging brain functional and metabolic changes in restless legs syndrome. Curr Neurol Neurosci Rep. 2013;13(9):372.
Gossard TR, Trotti LM, Videnovic A, St Louis EK. Restless legs syndrome: contemporary diagnosis and treatment. Neurotherapeutics. 2021;18(1):140-155.
Gonzalez-Latapi P, Malkani R. Update on restless legs syndrome: from mechanisms to treatment. Curr Neurol Neurosci Rep. 2019;19(8):54.
Yepes G, Guitart X, Rea W, et al. Targeting hypersensitive corticostriatal terminals in restless legs syndrome. Ann Neurol. 2017;82(6):951-960.
Buratti L, Petrelli C, Viticchi G, et al. Restless legs syndrome and periodic limb movements after lacunar stroke. Sleep Med. 2017;34:251-252.
Joseph V, Nagalli S. Periodic limb movement disorder. StatPearls. Vol 2022. StatPearls Publishing LLC; 2022.
Tuo HZ, Tian ZL, Cui YN, et al. Restless legs syndrome secondary to pontine infarction: clinical analysis of five cases. Chronic Dis Transl Med. 2017;3(3):186-190.
Schlesinger I, Erikh I, Nassar M, Sprecher E. Restless legs syndrome in stroke patients. Sleep Med. 2015;16(8):1006-1010.
Gupta A, Shukla G, Mohammed A, Goyal V, Behari M. Restless legs syndrome, a predictor of subcortical stroke: a prospective study in 346 stroke patients. Sleep Med. 2017;29:61-67.
Ferini-Strambi L, Walters AS, Sica D. The relationship among restless legs syndrome (Willis-Ekbom disease), hypertension, cardiovascular disease, and cerebrovascular disease. J Neurol. 2014;261(6):1051-1068.
Walters AS, Rye DB. Review of the relationship of restless legs syndrome and periodic limb movements in sleep to hypertension, heart disease, and stroke. Sleep. 2009;32(5):589-597.
Bassetti CLA, Randerath W, Vignatelli L, et al. EAN/ERS/ESO/ESRS statement on the impact of sleep disorders on risk and outcome of stroke. Eur Respir J. 2020;55(4):1901104.
Katsanos AH, Kosmidou M, Konitsiotis S, et al. Restless legs syndrome and cerebrovascular/cardiovascular events: systematic review and meta-analysis. Acta Neurol Scand. 2018;137(1):142-148.
Shukla G, Gupta A, Pandey RM, et al. What features differentiate unilateral from bilateral restless legs syndrome? A comparative observational study of 195 patients. Sleep Med. 2014;15(6):714-719.
Ohayon MM, O'Hara R, Vitiello MV. Epidemiology of restless legs syndrome: a synthesis of the literature. Sleep Med Rev. 2012;16(4):283-295.
Trenkwalder C, Allen R, Högl B, Paulus W, Winkelmann J. Restless legs syndrome associated with major diseases: a systematic review and new concept. Neurology. 2016;86(14):1336-1343.
Wang XX, Feng Y, Tan EK, Ondo WG, Wu YC. Stroke-related restless legs syndrome: epidemiology, clinical characteristics, and pathophysiology. Sleep Med. 2022;90:238-248.

Auteurs

Stefania Kalampokini (S)

Department of Neurology, Nicosia General Hospital and Medical school, University of Cyprus, Nicosia, Cyprus.

Sotiris Poyiadjis (S)

Radboud University, Nijmegen, Netherlands.

George D Vavougios (GD)

Department of Neurology, Nicosia General Hospital and Medical school, University of Cyprus, Nicosia, Cyprus.

Artemios Artemiadis (A)

Department of Neurology, Nicosia General Hospital and Medical school, University of Cyprus, Nicosia, Cyprus.

Panagiotis Zis (P)

Department of Neurology, Nicosia General Hospital and Medical school, University of Cyprus, Nicosia, Cyprus.

Georgios M Hadjigeorgiou (GM)

Department of Neurology, Nicosia General Hospital and Medical school, University of Cyprus, Nicosia, Cyprus.

Panagiotis Bargiotas (P)

Department of Neurology, Nicosia General Hospital and Medical school, University of Cyprus, Nicosia, Cyprus.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH